Insights from BCC Research

Studies Find Non-Opioid Meds as Effective for Pain Relief as Opioids

Posted by Clayton Luz on Mar 29, 2018 10:00:00 AM

NonOpioid PainTreatment Drugs

In 2016, 116 people died every day from opioid-related drug overdoses, according to the U.S. Department of Health and Services. Opioid-involved deaths are continuing to increase in the United States. More than three out of five drug overdose deaths involve an opioid.

Read More

Topics: Healthcare, Life Sciences

Healthcare Cloud Computing Market Expanding Amidst Security Concerns

Posted by BCC Research Editorial on Feb 16, 2018 10:00:00 AM

Healthcare Cloud Computing Market.jpg

The use of cloud networks in healthcare settings is crossing the threshold from cautious consideration to widespread adoption, which is contributing to strong growth as the global market is forecasts to reach $35.0 billion in 2022 at a compound annual growth rate (CAGR) of 11.6% from 2017-2022.

Read More

Topics: Healthcare, Life Sciences

Cloud Computing Is Capturing Healthcare

Posted by Laurie L. Sullivan on Feb 1, 2018 12:45:00 PM

Cloud_Computing.pngInitially approached with caution by healthcare organizations, cloud computing is becoming more widely adopted in this arena. As cost savings outweighed potential data protection concerns, cloud adoption in healthcare increased during 2017. Healthcare information technology (IT) systems are expensive to implement, update and maintain. Cloud economics changes that by shifting from individual budgets to cost-sharing models enabled by private, multitenant and in some cases, public clouds. These trends are shifting in favor of increased IT spending on cloud hardware, software and networks.

Read More

Topics: Life Sciences, Healthcare

Continuous Glucose Monitoring Finds Sweet Spot Without the Sting

Posted by Laurie L. Sullivan on Jan 9, 2018 2:30:00 PM

Glucose Monitor.jpegThe continuous glucose monitoring market, introduced nearly 20 years ago, is presently experiencing strong growth as diabetics, physicians, hospitals and clinics witness the benefits these devices can lend to the management of glucose levels. The market now includes blood glucose monitors, diabetes test strips, insulin durable and patch pumps, glucose sensors, and transmitters and receivers. The global market for continuous glucose monitoring equipment is expected to top $20.6 billion by 2022, according to a new study by BCC Research, at a five-year compound annual growth rate (CAGR) of 10.1%.

Read More

Topics: Healthcare, Life Sciences